Fidaxomicin Inhibits Spore Production in Clostridium difficile

Fidaxomicin (FDX) is a novel antimicrobial agent with narrow-spectrum and potent bactericidal activity against Clostridium difficile. In recent clinical trials, FDX was superior to vancomycin in preventing recurrences of C. difficile infection. A possible mechanism of reducing recurrence may be thro...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Babakhani, Farah, Bouillaut, Laurent, Gomez, Abraham, Sears, Pamela, Nguyen, Ly, Sonenshein, Abraham L.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2012
Teme:
Supplement Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3388029/
https://ncbi.nlm.nih.gov/pubmed/22752866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cis453
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki